Evaluation of cardioprotective activity of Terminalia arjuna leaf extract against Doxorubicin induced Cardiotoxicity Wistar rats
Kajal Bhati, Ayasha Saiffi, Mohammad Rashid, Suhana, Sanjar Alam
ABSTRACT
Doxorubicin is a powerful chemotherapeutic agent commonly used in the treatment of cancer, but the therapeutic use of this drug is frequently limited due to its cardiotoxic effects, which are mainly linked to oxidative stress, reactive oxygen species production and consequent myocardial damage. This study has been carried out to examine the possible cardioprotective role of the leaf extract of the plant, Terminalia arjuna, on doxorubicin-induced cardiac toxicity in Wistar rats. Cardiotoxicity was induced using doxorubicin, and the protective effectssofthesextract were assessed through biochemical,santioxidant, andshistopathological parameters. Doxorubicin administration significantly increased serum cardiac biomarkers such assCK-MB,sLDH,sSGOT, SGPT, and Troponin-I,swhile decreasing antioxidant enzymes including SOD, Catalase, and GSH. It also elevated lipid peroxidation (MDA), produced ECG abnormalities, and caused severe myocardial degeneration. Treatment with Terminalia arjunaleafsextractssignificantly attenuated thesesalterations in asdose-dependent manner. The 400 mg/kg dose showed maximum cardioprotective activity, restoring antioxidant status, reducing cardiac biomarker levels, improving ECG parameters, and preserving myocardial architecture.The cardioprotective effects maysbe attributed to the presencesof flavonoids, phenolicscompounds, tannins,sand triterpenoids possessing potent antioxidantsand membrane-stabilizing properties. The study concludes that Terminalia arjuna leaf extract is a promising natural cardioprotective agent against doxorubicin-induced cardiac damage.
[Full Text Article]

